If a risk factor for eye problems is identified, and someone has these factors, then it may be a reason for a person to avoid these medications. MNT also spoke with Howard Krauss, MD, surgical neuro-ophthalmologist and director of Pacific Neuroscience Institutes Eye, Ear & Skull Base Center at Providence Saint Johns Health Center in Santa Monica, CA, about this study
Click here to read the Cover Story, Specialists discuss concerns over impact of semaglutide on the eye.
The following is an overview of what the legal process typically involves: Free Initial Consultation: First, your GLP-1 lawsuit attorney will meet with you to review your medical history, the GLP-1 medication you took, the injuries you suffered, and the timeline of your medical treatment
95% CI -60.7, -5.6
"And that is, when you stop the microdosing, you will gain the weight back." That is also often the case when patients stop taking full doses of GLP-1 drugs